Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

1.6K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.6K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

327
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
327
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

886
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
886
Energy-releasing Steps of Glycolysis01:28

Energy-releasing Steps of Glycolysis

146.7K
Glycolysis is divided into two phases based on whether energy is utilized or released. While the first phase consumes ATP, the second phase produces energy in the form of ATP and NADH. The energy is released over a sequence of reactions that turns G3P into pyruvate. The energy-releasing phase—steps 6-10 of glycolysis—occurs twice, once for each of the two 3-carbon sugars produced during steps 1-5 of the first phase.
The first energy-releasing step—the 6th step of glycolysis...
146.7K
ATP Energy Storage and Release01:31

ATP Energy Storage and Release

14.3K
ATP is a highly unstable molecule. Unless quickly used to perform work, ATP spontaneously dissociates into ADP and inorganic phosphate (Pi), and the free energy released during this process is lost as heat. The energy released by ATP hydrolysis is used to perform work inside the cell and depends on a strategy called energy coupling. Cells couple the exergonic reaction of ATP hydrolysis with endergonic reactions, allowing them to proceed.
One example of energy coupling using ATP involves a...
14.3K
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

428
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
428

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A fractal kinetics SI model can explain the dynamics of COVID-19 epidemics.

PloS one·2020
Same author

Chromosomal origin of replication coordinates logically distinct types of bacterial genetic regulation.

NPJ systems biology and applications·2020
Same author

EEG for Current With Two-Dimensional Support.

IEEE transactions on bio-medical engineering·2018
Same author

Functional morphometry for the estimation of the alveolar surface area in prematurely-born infants.

Respiratory physiology & neurobiology·2018
Same author

A chemical energy approach of avascular tumor growth: multiscale modeling and qualitative results.

SpringerPlus·2015
Same author

On the stability of a spherical tumour.

Mathematical medicine and biology : a journal of the IMA·2015

Related Experiment Video

Updated: Jan 27, 2026

Structure-Based Simulation and Sampling of Transcription Factor Protein Movements along DNA from Atomic-Scale Stepping to Coarse-Grained Diffusion
09:17

Structure-Based Simulation and Sampling of Transcription Factor Protein Movements along DNA from Atomic-Scale Stepping to Coarse-Grained Diffusion

Published on: March 1, 2022

3.6K

Monte Carlo simulations in drug release.

Kosmas Kosmidis1, George Dassios2

  • 1Division of Theoretical Physics, Physics Department, Aristotele University of Thessaloniki, 54124, Thessaloniki, Greece. kosmask@auth.gr.

Journal of Pharmacokinetics and Pharmacodynamics
|March 19, 2019
PubMed
Summary

Monte Carlo simulations offer advanced methods for studying controlled drug release, moving beyond basic diffusion models. These simulations reveal how substrate variations impact drug release profiles, enhancing pharmacokinetic understanding.

Keywords:
Drug releaseMonte Carlo simulationsNumerical methods

More Related Videos

Modeling and Simulations of Olfactory Drug Delivery with Passive and Active Controls of Nasally Inhaled Pharmaceutical Aerosols
15:04

Modeling and Simulations of Olfactory Drug Delivery with Passive and Active Controls of Nasally Inhaled Pharmaceutical Aerosols

Published on: May 20, 2016

11.4K
Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions
07:49

Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions

Published on: September 17, 2014

11.9K

Related Experiment Videos

Last Updated: Jan 27, 2026

Structure-Based Simulation and Sampling of Transcription Factor Protein Movements along DNA from Atomic-Scale Stepping to Coarse-Grained Diffusion
09:17

Structure-Based Simulation and Sampling of Transcription Factor Protein Movements along DNA from Atomic-Scale Stepping to Coarse-Grained Diffusion

Published on: March 1, 2022

3.6K
Modeling and Simulations of Olfactory Drug Delivery with Passive and Active Controls of Nasally Inhaled Pharmaceutical Aerosols
15:04

Modeling and Simulations of Olfactory Drug Delivery with Passive and Active Controls of Nasally Inhaled Pharmaceutical Aerosols

Published on: May 20, 2016

11.4K
Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions
07:49

Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions

Published on: September 17, 2014

11.9K

Area of Science:

  • Pharmacokinetics
  • Computational Modeling
  • Drug Delivery Systems

Background:

  • Controlled drug release is crucial for effective therapeutics.
  • Traditional diffusion models (Fickian) have limitations in complex systems.
  • Prof. Panos Macheras pioneered Monte Carlo applications in drug release.

Purpose of the Study:

  • To present advanced Monte Carlo simulation methods for controlled drug release.
  • To investigate drug release beyond classical Fickian diffusion.
  • To explore the impact of substrate heterogeneity on release profiles.

Main Methods:

  • Simple sampling Monte Carlo simulations.
  • Agent-based simulations.
  • Numerical methods for pharmacokinetic analysis.

Main Results:

  • Demonstrated the effectiveness of Monte Carlo simulations in modeling complex drug release.
  • Illustrated the significant influence of substrate heterogeneity on drug release kinetics.
  • Showcased applications beyond classical diffusion equations.

Conclusions:

  • Monte Carlo simulations provide powerful tools for understanding controlled drug release.
  • Substrate heterogeneity plays a profound role in drug release profiles.
  • Agent-based and numerical methods advance pharmacokinetic studies.